Following a review of three recent studies, the European Medicines Agency’s Pharmacovigilance Risk Assessment Committee (PRAC) has recommended that a Pregnancy Prevention Programme (PPP) be introduced around the use of the Anti-Seizure Medication Topiramate (Topamax).
We will be meeting with the Minister for Social Protection in the weeks following #IEC2023.
A new international study has highlighted areas of DNA that might be involved in the development of epilepsy.
For the first time in almost 25 years, we will be moving to the future without Training for Success (TFS) as part of our service.
It’s back to school season so we wanted to remind people how Epilepsy Ireland help support you, your child, and their school with their return to the classroom and provide some important information on epilepsy and school.
First and foremost, it is recommended that any child with epilepsy who could have seizures in school has an individualised Care Plan. These plans should cover:
The EMA have provided an update on their ongoing assessment of a paper on the risks of paternal exposure to valproate.
In advance of SUDEP Action Day on October 18th, we are seeking responses to an important survey aimed at understanding the awareness of SUDEP amongst the epilepsy community.
In advance of the International Epilepsy Congress, Epilepsy Ireland have called on the Government to become global leaders in regard to the implementation of the WHO Intersectoral Global Action Plan on Epilepsy and other neurological conditions.
Later this week, Wayne O'Reilly will be awarded with a Golden Light award in recognition of his contributions to epilepsy awareness!
We have issued a very important survey aimed at understanding the experiences of all those who engage with Epilepsy Ireland. Can you help us by providing your feedback?